CEO - Gene Therapy Start Up

CEO - Gene Therapy Start Up

Job Title: CEO - Gene Therapy Start Up
Contract Type: Permanent
Location: London
Salary: Equity based role
Start Date: Immediately Available
Reference: J16111SS
Contact Name: Steve Smith
Contact Email:
Job Published: August 19, 2019 17:05

Job Description

With a highly impressive set of early data for both therapeutic targets and gene therapy delivery technology, this start-up biotech now has an opportunity for a seasoned advanced therapies CEO, with extensive investor networks and fundraising experience to join their venture, short or long term.

The company's gene therapy delivery technology has so far been used to target a rare neuromuscular disease and several non-rare targets, and has demonstrated several major competitive advantages vs. their competitors, to include;
- Significantly reduced toxicity
- Additional ability to deliver to the brain and heart
- Significantly improved therapeutic effects with re-administration
- Commercial Scalablity
- Can be applied to thousands of rare disease and non-rare disease targets

Full, latest, non-confidential slides and more detailed information is available to suitable executives, ahead of making an official application. 

Following successful fundraising efforts; a long term, full time CEO option will also be available, if appropriate.

For more information please contact Steve Smith, Head of Rare Diseases and Cell & Gene Therapy on or +44 (0)1403 216216.